Intestinal methane production in obese individuals is associated with a higher body mass index

GI Motility Program, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Gastroenterology and Hepatology 01/2012; 8(1):22-8.
Source: PubMed


Obesity is an epidemic that affects 1 in 3 individuals in the United States, and recent evidence suggests that enteric microbiota may play a significant role in the development of obesity. This study evaluated the association between methanogenic archaea and obesity in human subjects.
Subjects with a body mass index (BMI) of 30 kg/m² or higher were prospectively recruited from the weight loss program of a tertiary care medical center. Subjects who met the study's inclusion criteria were asked to complete a questionnaire that included a series of visual analogue scores for bowel symptom severities. Subjects then provided a single end-expiratory breath sample to quantitate methane levels. Bivariate and multivariate analyses were used to determine associations with BMI.
A total of 58 patients qualified for enrollment. Twenty percent of patients (n = 12) had breath test results that were positive for methane (>3 parts per million [ppm]), with a mean breath methane concentration of 12.2±3.1 ppm. BMI was significantly higher in methane-positive subjects (45.2±2.3 kg/m²) than in methane-negative subjects (38.5±0.8 kg/m²; P=.001). Methane-positive subjects also had a greater severity of constipation than methane-negative subjects (21.3±6.4 vs 9.5±2.4; P=.043). Multiple regression analysis illustrated a significant association between BMI and methane, constipation, and antidepressant use. However, methane remained an independent predictor of elevated BMI when controlling for antidepressant use (P<.001) and when controlling for both constipation and antidepressant use (6.55 kg/m² greater BMI; P=.003).
This is the first human study to demonstrate that a higher concentration of methane detected by breath testing is a predictor of significantly greater obesity in overweight subjects.

Download full-text


Available from: Edy Soffer, Oct 06, 2014
    • "Zhang et al. (2009) showed higher numbers of methanogenic Archaea in obese individuals than in normal-weight subjects, and the loss of archaeal methanogens after gastric bypass surgery. In this sense, Basseri et al. (2012) have proposed that methane detected by breath testing may be a predictor of obesity. In general, the data that link obesity and specific gut microbiota remain uncertain as to whether the gut microbiota plays a causative role in obesity or it is modulated in response to the diet in obesity or the obese state itself. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The recent research focus on the human microbiota has provided data which suggests that the composition of the gut microbiota can play an important role in the modulation of body weight and of related mucosal and systemic immune responses. However, recent results from human and animal studies have raised the debate about whether specific microbial groups play a causative role in obesity or if the gut microbiota is modulated in response to diet or the obese state itself. Studies targeting selective alterations in the gut microbiota to control weight gain through the intake of probiotics and/or prebiotics or modulating undesirable populations through the use of antimicrobials or transplantation of faecal microbiota have provided promising results. Nonetheless, further placebo-controlled, double blind human studies are still required. Likewise, while it is now well accepted that obesity is followed by a low grade inflammatory response, more research studies are needed to unravel the mechanisms that would explain how different microbiota profiles affect the mucosal and systemic immune responsiveness, the intestinal barrier function and the development of adiposity.
    Trends in Food Science & Technology 11/2013; 34(1):44–53. DOI:10.1016/j.tifs.2013.08.007 · 4.65 Impact Factor
  • Source
    • "Undoubtedly, stressful life events have also been associated with an increased frequency of functional constipation [129]; however, this does not remove microbes from playing an important role in the modulation of gut motility and any potential systemic health consequences of chronic constipation. As discussed later, methane-producing intestinal microbes have been linked with constipation and are now emerging as a key part of reflex contraction and altered motility in IBS [130-133]. As we will discuss in Part III, beneficial microbes have recently been shown to reduce physio-behavioral signs associated with colorectal distention. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mental health disorders, depression in particular, have been described as a global epidemic. Research suggests that a variety of lifestyle and environmental changes may be driving at least some portion of the increased prevalence. One area of flourishing research involves the relationship between the intestinal microbiota (as well as the related functional integrity of the gastrointestinal tract) and mental health. In order to appreciate the recent scientific gains in this area, and its potential future directions, it is critical to review the history of the topic. Probiotic administration (e.g. Lactobacillus) and fecal microbiota transfer for conditions associated with depression and anxiety is not a new concept. Here, in the first of a 3-part series, we begin by reviewing the origins of the contemporary research, providing a critical appraisal of what has become a revisionist history of the controversial term 'autointoxication'. We argue that legitimate interests in the gut-brain-microbiota connection were obscured for decades by its association with a narrow historical legacy. Historical perspectives provide a very meaningful context to the current state of the contemporary research as outlined in parts II and III.
    Gut Pathogens 03/2013; 5(1):5. DOI:10.1186/1757-4749-5-5 · 2.28 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The presence of melatonin in plants is universal. Evidence has confirmed that a major portion of the melatonin is synthesized by plants themselves even though a homologue of the classic arylalkylamine N-acetyltransferase (AANAT) has not been identified as yet in plants. Thus, the serotonin N-acetylating enzyme in plants may differ greatly from the animal AANAT with regard to sequence and structure. This would imply multiple evolutionary origins of enzymes with these catalytic properties. A primary function of melatonin in plants is to serve as the first line of defence against internal and environmental oxidative stressors. The much higher melatonin levels in plants compared with those found in animals are thought to be a compensatory response by plants which lack means of mobility, unlike animals, as a means of coping with harsh environments. Importantly, remarkably high melatonin concentrations have been measured in popular beverages (coffee, tea, wine, and beer) and crops (corn, rice, wheat, barley, and oats). Billions of people worldwide consume these products daily. The beneficial effects of melatonin on human health derived from the consumption of these products must be considered. Evidence also indicates that melatonin has an ability to increase the production of crops. The mechanisms may involve the roles of melatonin in preservation of chlorophyll, promotion of photosynthesis, and stimulation of root development. Transgenic plants with enhanced melatonin content could probably lead to breakthroughs to increase crop production in agriculture and to improve the general health of humans.
    Journal of Experimental Botany 01/2012; 63(2):577-97. DOI:10.1093/jxb/err256 · 5.53 Impact Factor
Show more